2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Complex traits and polygenic disorders<br />
py, Novosibirsk, Russian Federation.<br />
Due to key role <strong>of</strong> mitochondria in cell energy production, mitochondrial<br />
DNA is considered as candidate locus for different common diseases<br />
as well as for predisposing to longevity. Some associations <strong>of</strong> different<br />
mtDNA haplogroups with longevity were shown in <strong>European</strong> populations.<br />
To explore possible associations <strong>of</strong> mtDNA polymorphisms with<br />
longevity in population <strong>of</strong> Siberian part <strong>of</strong> Russia, we have studied<br />
mtDNA in samples <strong>of</strong> long-livers (>90 years old) from Tomsk and Novosibirsk<br />
(N=235) by sequencing HVS1 region and restriction analysis<br />
for haplogroup assignment. We have compared frequencies <strong>of</strong> main<br />
<strong>European</strong> haplogroups (H, H1, U4, U5, K, J, T) and some frequent<br />
polyphyletic HVS1 polymorphisms (16189, 16311, 16362, etc) in longlivers<br />
group with mtDNA data on Tomsk population. No significant differences<br />
were found for haplogroups, as well as for big clusters (J+T,<br />
U, H+HV+V). At the same time, the long-livers had higher frequency<br />
<strong>of</strong> T16189C polymorphism (21.3% comparing to 12.2% in population,<br />
P=0.04). There was no difference between long-livers and population<br />
in “haplogroup composition” <strong>of</strong> the 16189C group (main contributors<br />
were haplogroups H1 and U5). T16189C variant is known as associated<br />
with diabetes in adults, increased body mass index and insulin<br />
resistance. In contrast, our results suggest that this variant may have<br />
also positive influence on fitness, thus favoring for longevity. The study<br />
was supported by RFBR grant 07-04-01526a.<br />
P09.075<br />
infant c677t genotype <strong>of</strong> the mtHFR gene as a risk factor nonsyndromic<br />
cleft lip with/ without palate<br />
K. Ulucan1 , D. Kirac2 , T. Akcay3 , D. Javadova4 , G. Koc4 , D. Ergec5 , A. I.<br />
Güney4 ;<br />
1Marmara University, Faculty <strong>of</strong> Dentistry, Department <strong>of</strong> Medical Biology and<br />
<strong>Genetics</strong>, Istanbul, Turkey, 2Yeditepe University, Faculty <strong>of</strong> Medicine, Department<br />
<strong>of</strong> Biochemistry, Istanbul, Turkey, 3Marmara University, Faculty <strong>of</strong> Medicine,<br />
Department <strong>of</strong> Pediatric Endocrinology, Istanbul, Turkey, 4Marmara University,<br />
Faculty <strong>of</strong> Medicine, Department <strong>of</strong> Medical <strong>Genetics</strong>, Istanbul, Turkey,<br />
5Maltepe University, Faculty <strong>of</strong> Medicine, Department <strong>of</strong> Medical Biology and<br />
<strong>Genetics</strong>, Istanbul, Turkey.<br />
5,10- Methylenetetrahydr<strong>of</strong>olate reductase (MTHFR) gene is located<br />
on 1p36.3 and involved in folate metabolism. It has two common gene<br />
variants, C677T and A1298C. C677T homozygosity is associated with<br />
several congenital anomalies, mostly neural tube defects. Non-syndromic<br />
cleft lip with/without palate (NSCLP) is one <strong>of</strong> the most common<br />
congenital anomalies, with a prevalance <strong>of</strong> 1/1000 in Caucasians.<br />
It is a multifactorial pathology affected from different loci and genes,<br />
environmental factors also implicated in NSCLP. To date C677T, in the<br />
terms <strong>of</strong> NSCLP and MTHFR, has either conflicting results or couldn’t<br />
be replicated properly. Our aim is to determine a relation between infants’<br />
MTHFR C677T polymorphism and (NSCLP) in Turkish population.<br />
We have established 100 NSCLP patients without any family history<br />
<strong>of</strong> CLP and 100 controls. PCR- RFLP method was performed for the<br />
determination <strong>of</strong> MTHFR gene by using specific primers and Hinf I<br />
restriction enzyme.<br />
CC (wild type) frequencies were %39 and %41 in NSCLP patients and<br />
controls respectively. %43 <strong>of</strong> the patients and %47 <strong>of</strong> the controls were<br />
CT and %18 <strong>of</strong> the patients and %12<strong>of</strong> the controls were TT (mutant)<br />
for the MTHFR C677T allele.<br />
No statistically significant differences were detected between study<br />
and control groups. Our study suggests that only MTHFR C677T genotyping<br />
in infants may be a useless approach to suggest as a risk<br />
factor for NSCLP in Turkish population.<br />
P09.076<br />
the mtHFR c677t polymorphism increase the risk for renal<br />
involvement in type 2 diabetic patients<br />
D. Cimponeriu1 , P. Apostol1 , M. Stavarachi1 , M. Toma1 , I. Radu1 , A. Craciun2 ,<br />
N. Panduru2 , C. Serafinceanu2 , L. Gavrila1 ;<br />
1 2 Institute <strong>of</strong> <strong>Genetics</strong>, Bucharest, Romania, N Paulescu Institute, Bucharest,<br />
Romania.<br />
Renal disease is one <strong>of</strong> the most common complications <strong>of</strong> diabetic<br />
patients. Many studies suggest that MTHFR (Methylentetrahydr<strong>of</strong>olate<br />
reductase) and TGF-beta polymorphisms increases the risk for renal<br />
involvement in diabetic patients.<br />
The purpose <strong>of</strong> this case-control study was to estimate the association<br />
between MTHFR C677T and TGF-beta C-509T polymorphisms and<br />
renal failure in diabetic patients.<br />
Clinical information and biological samples were collected from dialyzed<br />
patients with type I diabetes (n=116, male: 56%, dialysis: 1,6±0,8<br />
years), type II diabetes (n=123, male: 55.28%, 2,4±1,2, dialysis:<br />
2,3±1,2 years) or chronic glomerulonephritis (n=121, male: 49.58%,<br />
dialysis: 1,7±0,9 years) and from healthy subjects (n=494, fasting glycemia<br />
93.2±8.2 mg/dl). Healthy subjects were selected to be matched<br />
for age and gender with patients. All subjects selected for this study<br />
were unrelated Romanian Caucasians.<br />
Blood samples from all subjects were used for DNA extraction. DNA<br />
samples were used for genotyping TGFb -509 and MTHFR C677T<br />
polymorphisms using PCR and PCR RFLP methods.<br />
In the case <strong>of</strong> MTHFR C677T the distribution <strong>of</strong> genotypes remains<br />
significant only when T2DM patients and controls were compared<br />
(p=0,019). The results showed no association between TGFbeta and<br />
the risk for renal failure in diabetic or nondiabetic patients (OR~1).<br />
In conclusion, our study demonstrates:<br />
1. The MTHFR C677T is associated with ESRD in type 2 diabetic patients.2.<br />
TGF-beta genotypes are not significant risk factors for development<br />
<strong>of</strong> ESRD.<br />
(Project: Romania, PNII-IDEI, code 2150)<br />
P09.077<br />
An investigation <strong>of</strong> polymorphisms in ctLA-4 gene for<br />
association with multiple sclerosis in iranians<br />
M. R. Noori-Daloii, A. Heidari, M. Keramati-Pour, A. Rashidi-Nejad, A.<br />
Amirzargar, A. Sahmani;<br />
Tehran Univ. <strong>of</strong> Medical Sciences, Tehran, Islamic Republic <strong>of</strong> Iran.<br />
Multiple sclerosis (MS), a chronic inflammatory demyelinating disease<br />
<strong>of</strong> the central nervous system is believed to have a T cell-mediated<br />
autoimmune etiology. The cytotoxic T lymphocyte antigen 4 (CTLA-4)<br />
gene is a strong candidate for the involvement in autoimmune diseases.<br />
To examine the genetic association <strong>of</strong> the CTLA-4 gene locus<br />
with MS, in a case-control design, we analyzed three single nucleotide<br />
polymorphisms (SNPs) <strong>of</strong> the CTLA-4 gene including -318 C/T, +49A/<br />
G and CT60 in 135 unrelated Iranian relapsing-remitting MS patients<br />
and 135 healthy subjects using PCR-RFLP method. The overall genotype<br />
frequencies <strong>of</strong> -318 CC, CT and TT were 79.6%, 18.9% and 1.5%,<br />
respectively. Regarding the +49A/G SNP the overall genotype frequencies<br />
for AA, AG and GG were 29.6%, 53% and 17.4%, respectively and<br />
for CT60 SNP the overall genotype frequencies for AA, AG and GG<br />
were 19.3%, 50.7 and 30%, respectively The distribution <strong>of</strong> CTLA-4<br />
(-318 C/T) genotype and allele frequencies did not significantly differ<br />
between MS patients and healthy subjects. In conclusion, there may<br />
not be any association between CTLA-4 gene polymorphisms and MS<br />
development.<br />
Key words: Allelic association; CTLA-4; multiple sclerosis; RFLP; Single<br />
nucleotide polymorphism<br />
P09.078<br />
Polymorphisms <strong>of</strong> hemochromatosis and transferrin genes in<br />
multiple sclerosis<br />
N. Starcevic Cizmarevic 1 , S. Ristić 1 , L. Lovrečić 2 , J. Sepčić 3 , B. Brajenović-<br />
Milić 1 , A. Buretic Tomljanovic 1 , M. Kapović 1 , B. Peterlin 2 ;<br />
1 Department <strong>of</strong> Biology and Medical <strong>Genetics</strong>, School <strong>of</strong> Medicine, Rijeka,<br />
Croatia, 2 Division <strong>of</strong> Medical <strong>Genetics</strong>, UMC, Ljubljana, Slovenia, 3 Postgraduate<br />
Study, School <strong>of</strong> Medicine, Rijeka, Croatia.<br />
Recent evidence has indicated a role for iron dysregulation in disease<br />
pathogenesis. We tested the hypothesis that polymorphisms in<br />
HFE (C282Y and H63D) and TF (C1 and C2) genes, and interactions<br />
among these polymorphisms, influence predisposition to and clinical<br />
presentation <strong>of</strong> multiple sclerosis (MS).<br />
Three hundred and sixty-eight MS patients and 368 healthy controls<br />
were genotyped by PCR-RFLP method.<br />
Statistically significant higher frequency <strong>of</strong> the C282Y mutation carriers<br />
was observed in patients with secundary-progressive or relapsing-remitting<br />
MS (7.7%) than in the control group (3.8%) (p=0.026). A<br />
significantly earlier age <strong>of</strong> onset was found in carriers <strong>of</strong> the C282Y<br />
mutation (p=0.035). The frequency <strong>of</strong> H63D homozygotes was higher<br />
(2.8%) in control group than in MS patients (0.7%) with borderline significance<br />
(p=0.050). We found no corelation between H63D mutation<br />
and disease behavior (p>0.05). We were unable to detect significant